Shares of Shilpa Medicare Ltd., a company engaged in the manufacturing of active pharma ingredients, formulation and development service, dropped more than 4 percent in trade on Friday after the company reported a net loss for the March quarter, compared to a net profit in the year-ago quarter.
Revenue for the quarter fell 22.6 percent to Rs 263.5 crore during the quarter. It remained flat on a sequential basis.
EBITDA, or earnings before interest tax, depreciation and amortisation, nearly halved from last year to Rs 38.22 crore during the quarter versus Rs 73.7 crore last year. However, the operating profit improved quarter-on-quarter from Rs 31.3 crore in December.
EBITDA Margins stood at 14.5 percent in the March quarter compared with 21.6 percent in the same quarter a year ago and 12 percent in the previous quarter.
Shares of Shilpa Medicare fell 2.8 percent to Rs 237.7 crore.
